Portals / Pharma
Entries in this portal
Personalized RNA Medicine
Programmable RNA platforms can compress the path from molecular insight to tailored therapy, especially for rare or rapidly changing targets.
Engineered Cell Therapies
Living cells engineered to fight disease have transformed some blood cancers and are being pushed toward solid tumors, autoimmunity, and off-the-shelf manufacturing.
Longevity Pharma Pipeline
Aging-targeted pharma is moving from supplement claims toward indication-led trials, combination logic, and prevention endpoints.
Targeted Protein Degradation
Instead of blocking a protein, degraders instruct the cell to destroy it — expanding the range of disease targets beyond what traditional inhibitors can reach.
Medical Nanorobots
Programmable nanoscale devices — often built from DNA — can carry drugs and release them on a molecular cue, with early tumor-targeting demonstrations in animals.